Variant report

Variant	esv33277
Chromosome Location	chr11:104944762-104969485
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr11:104948119-104948459	GM12878	blood:	n/a	chr11:104948321-104948332
2	CEBPB	chr11:104951169-104951316	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr11:104948635-104948827	HepG2	liver:	n/a	chr11:104948658-104948669
4	CEBPB	chr11:104951117-104951358	IMR90	lung:	n/a	n/a
5	CTCF	chr11:104948711-104948822	Kidney_OC	kidney:	n/a	n/a
6	CTCF	chr11:104945420-104945570	BE2_C	brain:	n/a	n/a
7	CTCF	chr11:104945360-104945510	AG09309	skin:	n/a	n/a
8	CTCF	chr11:104945394-104945576	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr11:104963680-104963830	HMEC	breast:	n/a	n/a
10	CTCF	chr11:104963760-104963910	HPAF	blood vessel:	n/a	n/a
11	CTCF	chr11:104963580-104963730	HMEC	breast:	n/a	n/a
12	CTCF	chr11:104965975-104966006	GM20000	blood:	n/a	n/a
13	E2F4	chr11:104945873-104946021	MCF10A-Er-Src	breast:	n/a	n/a
14	EBF1	chr11:104946814-104946837	GM12878	blood:	n/a	chr11:104946815-104946826
15	FOS	chr11:104963677-104964022	HUVEC	blood vessel:	n/a	chr11:104963836-104963847 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
16	FOS	chr11:104944266-104944785	HUVEC	blood vessel:	n/a	n/a
17	FOS	chr11:104948241-104948837	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr11:104963304-104963925	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
19	FOS	chr11:104963304-104963982	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
20	FOS	chr11:104948211-104948907	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr11:104963328-104963986	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
22	FOS	chr11:104948928-104949030	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr11:104948262-104948729	MCF10A-Er-Src	breast:	n/a	n/a
24	FOXA2	chr11:104960656-104960851	HepG2	liver:	n/a	n/a
25	GATA2	chr11:104963362-104963700	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
26	GATA3	chr11:104963287-104963717	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
27	GATA3	chr11:104963367-104963635	MCF-7	breast:	n/a	chr11:104963445-104963455
28	JUN	chr11:104945011-104945062	K562	blood:	n/a	n/a
29	MAFF	chr11:104947432-104947580	HepG2	liver:	n/a	n/a
30	MAFK	chr11:104947352-104947628	HepG2	liver:	n/a	n/a
31	MAFK	chr11:104947451-104947500	HepG2	liver:	n/a	n/a
32	MAZ	chr11:104963309-104963476	HepG2	liver:	n/a	n/a
33	MYC	chr11:104948687-104948837	MCF10A-Er-Src	breast:	n/a	n/a
34	MYC	chr11:104948580-104948902	MCF10A-Er-Src	breast:	n/a	n/a
35	MYC	chr11:104963252-104963831	MCF10A-Er-Src	breast:	n/a	n/a
36	MYC	chr11:104963215-104963761	MCF10A-Er-Src	breast:	n/a	n/a
37	POLR2A	chr11:104948645-104948863	MCF10A-Er-Src	breast:	n/a	n/a
38	POLR2A	chr11:104950926-104951391	Hela-S3	cervix:	n/a	n/a
39	POLR2A	chr11:104965649-104965802	MCF10A-Er-Src	breast:	n/a	n/a
40	POLR2A	chr11:104949545-104949721	MCF10A-Er-Src	breast:	n/a	n/a
41	POLR2A	chr11:104946338-104946365	MCF10A-Er-Src	breast:	n/a	n/a
42	POLR2A	chr11:104945881-104945963	GM12878	blood:	n/a	n/a
43	POLR2A	chr11:104956999-104957034	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr11:104949981-104950181	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr11:104951944-104951960	GM12878	blood:	n/a	n/a
46	POLR2A	chr11:104951882-104951942	GM12878	blood:	n/a	n/a
47	POLR2A	chr11:104964158-104964302	MCF10A-Er-Src	breast:	n/a	n/a
48	POLR2A	chr11:104963142-104963921	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr11:104967616-104967654	MCF10A-Er-Src	breast:	n/a	n/a
50	POLR2A	chr11:104968938-104969056	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:104966249-104966299	HUVEC	blood vessel:	n/a
2	chr11:104966249-104966299	H1-hESC	embryonic stem cell:	embryo
3	chr11:104966249-104966299	NB4	blood:	n/a
4	chr11:104966249-104966299	BE2_C	brain:	n/a
5	chr11:104966249-104966299	SAEC	small airway:	n/a
6	chr11:104966249-104966299	AG09319	gingival:	n/a
7	chr11:104966249-104966299	T-47D	breast:	n/a
8	chr11:104966249-104966299	PFSK-1	brain:	n/a
9	chr11:104966249-104966299	HRPEpiC	eye:	n/a
10	chr11:104966249-104966299	RPTEC	kidney:	n/a
11	chr11:104966249-104966299	LNCaP	prostate:	n/a
12	chr11:104966249-104966299	GM19239	blood:	n/a
13	chr11:104966249-104966299	HIPEpiC	eye:	n/a
14	chr11:104966249-104966299	HepG2	liver:	n/a
15	chr11:104966249-104966299	HPAEpiC	pulmonary alveolar:	n/a
16	chr11:104966249-104966299	GM12891	blood:	n/a
17	chr11:104966249-104966299	SK-N-SH_RA	brain:	n/a
18	chr11:104966249-104966299	ECC-1	luminal epithelium:	n/a
19	chr11:104966249-104966299	HCM	heart:	n/a
20	chr11:104966249-104966299	SKMC	muscle:	n/a
21	chr11:104966249-104966299	A549	lung:	n/a
22	chr11:104966249-104966299	PANC-1	pancreas:	n/a
23	chr11:104966249-104966299	HEK293	kidney:	embryo
24	chr11:104966249-104966299	NH-A	brain:	n/a
25	chr11:104966249-104966299	MCF10A-Er-Src	breast:	n/a
26	chr11:104966249-104966299	GM06990	blood:	n/a
27	chr11:104966249-104966299	AoSMC	blood vessel:	n/a
28	chr11:104966249-104966299	SK-N-MC	brain:	n/a
29	chr11:104966249-104966299	ProgFib	skin:	n/a
30	chr11:104966249-104966299	HMEC	breast:	n/a
31	chr11:104966249-104966299	GM12878	blood:	n/a
32	chr11:104966249-104966299	Caco-2	colon:	n/a
33	chr11:104966249-104966299	AG09309	skin:	n/a
34	chr11:104966249-104966299	GM12892	blood:	n/a
35	chr11:104966249-104966299	IMR90	lung:	fetal
36	chr11:104966249-104966299	PrEC	prostate:	n/a
37	chr11:104966249-104966299	HCF	heart:	n/a
38	chr11:104966249-104966299	HL-60	blood:	n/a
39	chr11:104966249-104966299	SK-N-SH	brain:	n/a
40	chr11:104966249-104966299	Hepatocyte	liver:	n/a
41	chr11:104966249-104966299	HAEpiC	amniotic membrane:	n/a
42	chr11:104966249-104966299	AG10803	skin:	n/a
43	chr11:104966249-104966299	MCF-7	breast:	n/a
44	chr11:104966249-104966299	BJ	skin:	n/a
45	chr11:104966249-104966299	NT2-D1	testis:	n/a
46	chr11:104966249-104966299	NHBE	bronchial:	n/a
47	chr11:104966249-104966299	K562	blood:	n/a
48	chr11:104966249-104966299	U87	brain:	n/a
49	chr11:104966249-104966299	AG04450	lung:	fetal
50	chr11:104966249-104966299	HRE	kidney:	n/a

Variant related genes	Relation type
CASP1P2	TF binding region
CASP1P2	CpG island

Extended variants
information (count: 845 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:845 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538133687	chr11:104944777-104944778	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs150231781	chr11:104944856-104944857	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs147901041	chr11:104944865-104944866	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs531133819	chr11:104944904-104944905	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs571589	chr11:104944907-104944908	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs561182240	chr11:104944912-104944913	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs182368862	chr11:104944962-104944963	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs530294541	chr11:104944974-104944975	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs78615993	chr11:104944975-104944976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs35663225	chr11:104945014-104945015	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs141580505	chr11:104945030-104945031	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs147031284	chr11:104945065-104945066	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs533498295	chr11:104945111-104945112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs185416489	chr11:104945125-104945126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs544506035	chr11:104945134-104945135	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs569240234	chr11:104945235-104945236	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs115165012	chr11:104945248-104945249	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs554880599	chr11:104945258-104945259	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs568306799	chr11:104945263-104945264	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs75817892	chr11:104945278-104945279	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs7943897	chr11:104945307-104945308	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs553644210	chr11:104945335-104945336	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs576872342	chr11:104945342-104945343	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs562999642	chr11:104945343-104945344	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs189778325	chr11:104945387-104945388	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs575619606	chr11:104945394-104945395	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs149644976	chr11:104945399-104945400	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs184049194	chr11:104945426-104945427	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs530272752	chr11:104945439-104945440	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs79948462	chr11:104945481-104945482	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs189033463	chr11:104945485-104945486	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs560434296	chr11:104945524-104945525	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs200155039	chr11:104945530-104945531	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs542842638	chr11:104945539-104945540	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs192926839	chr11:104945546-104945547	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs368514094	chr11:104945613-104945614	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs552688704	chr11:104945617-104945618	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs569302759	chr11:104945633-104945634	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs2509635	chr11:104945721-104945722	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs531733642	chr11:104945724-104945725	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs2509636	chr11:104945730-104945731	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs2509637	chr11:104945731-104945732	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs7933804	chr11:104945786-104945787	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs72986781	chr11:104945787-104945788	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs7108247	chr11:104945808-104945809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs371332675	chr11:104945847-104945848	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs1792777	chr11:104945868-104945869	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs565284652	chr11:104945870-104945871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs553951283	chr11:104945871-104945872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs570517679	chr11:104945876-104945877	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Melanoma	17363583	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Obesity	19966786	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:138 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:104942400-104947600	Weak transcription	HMEC	breast
2	chr11:104942400-104948000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr11:104942600-104948200	Weak transcription	NHEK	skin
4	chr11:104943000-104950000	Weak transcription	Monocytes-CD14+_RO01746	blood
5	chr11:104943200-104948600	Weak transcription	Primary monocytes fromperipheralblood	blood
6	chr11:104944000-104945400	Enhancers	HUVEC	blood vessel
7	chr11:104944400-104945000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
8	chr11:104945400-104950800	Weak transcription	HUVEC	blood vessel
9	chr11:104945800-104946200	Enhancers	Psoas Muscle	Psoas
10	chr11:104946200-104949000	Weak transcription	Psoas Muscle	Psoas
11	chr11:104947400-104949400	Enhancers	Skeletal Muscle Female	skeletal muscle
12	chr11:104947600-104949400	Enhancers	HMEC	breast
13	chr11:104948000-104948200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr11:104948000-104949200	Enhancers	Adipose Nuclei	Adipose
15	chr11:104948000-104949400	Enhancers	Skeletal Muscle Male	skeletal muscle
16	chr11:104948000-104953200	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr11:104948200-104949000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr11:104948200-104949400	Enhancers	NHEK	skin
19	chr11:104948600-104949000	Enhancers	Primary monocytes fromperipheralblood	blood
20	chr11:104948800-104949200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr11:104949000-104949400	Enhancers	Psoas Muscle	Psoas
22	chr11:104949000-104950200	Weak transcription	Primary monocytes fromperipheralblood	blood
23	chr11:104949200-104949400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr11:104949200-104951000	Weak transcription	Adipose Nuclei	Adipose
25	chr11:104949400-104950800	Weak transcription	NHEK	skin
26	chr11:104950000-104950200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr11:104950000-104950400	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr11:104950200-104950800	Enhancers	Primary monocytes fromperipheralblood	blood
29	chr11:104950200-104951000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
30	chr11:104950200-104953400	Enhancers	Cortex derived primary cultured neurospheres	brain
31	chr11:104950400-104950600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr11:104950400-104950800	Enhancers	Right Atrium	heart
33	chr11:104950400-104951200	Enhancers	Small Intestine	intestine
34	chr11:104950400-104951400	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr11:104950400-104951800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
36	chr11:104950400-104952000	Enhancers	iPS-15b Cell Line	embryonic stem cell
37	chr11:104950400-104952200	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr11:104950600-104950800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr11:104950600-104951000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr11:104950600-104951800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr11:104950600-104951800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
42	chr11:104950600-104952400	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr11:104950600-104953800	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr11:104950800-104951000	Enhancers	H1 Cell Line	embryonic stem cell
45	chr11:104950800-104951000	Enhancers	H9 Cell Line	embryonic stem cell
46	chr11:104950800-104951000	Enhancers	HUES64 Cell Line	embryonic stem cell
47	chr11:104950800-104951000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
48	chr11:104950800-104951000	Enhancers	Duodenum Mucosa	Duodenum
49	chr11:104950800-104951000	Weak transcription	Right Atrium	heart
50	chr11:104950800-104951200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links